Breast Ultrasound Market
Report ID: SQMIG35A3480
Report ID: SQMIG35A3480
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35A3480 |
Region:
Global |
Published Date: May, 2026
Pages:
157
|Tables:
118
|Figures:
72
Global Breast Ultrasound Market size was valued at USD 2.22 Billion in 2024 and is poised to grow from USD 2.38 Billion in 2025 to USD 4.22 Billion by 2033, growing at a CAGR of 7.42% during the forecast period (2026-2033).
Rising incidence and awareness of breast cancer is the primary driver of the breast ultrasound market, fueling demand for early accurate detection worldwide. These systems span portable handheld scanners to automated whole breast imaging and provide real time, adaptable views that complement mammography for dense breasts. The market is significant because ultrasound is low cost, uses no ionizing radiation and can be deployed at point of care to broaden outreach in underserved communities.
Over the past decades technology has evolved from simple B mode machines to high resolution transducers with elastography and contrast enhanced imaging, changing diagnostic pathways and care delivery. Building on technological progress, the integration of artificial intelligence and portable devices is a catalyst because it enhances diagnostic accuracy and expands access. When AI supports lesion detection and prioritization, radiology departments increase throughput and reduce missed cancers which motivates capital investment in automated whole breast platforms and elastography equipment. When handheld scanners are affordable, community screening vans and rural clinics can offer point of care exams, raising screening rates and enabling earlier treatment. Consequently manufacturers win opportunities to sell bundled hardware and software, payers consider broader reimbursement, and health systems adopt ultrasound guided biopsy and therapy monitoring more widely.
How is AI improving diagnostic accuracy in the breast ultrasound market?
AI is advancing the accuracy of breast ultrasound diagnosis through automated processes such as images, detection of lesions, and classification of lesions. Key features include automated detection overlays driven by AI, BI RADS standardization and real-time decision support that decreases variability between readers. The breast ultrasound market includes handheld devices, fully automated breast ultrasound systems and cloud-based analytics which together overcome the limitations of mammography for women with dense breast tissue by Reader Study and Systematic Review findings indicating improved detection rates, reduced false-positive results and more consistent interpretation by reading between the two skill levels of readers. These improvements support increased acceptance of ultrasound to help create new clinical pathways for screening and diagnosis, as well as to change vendor and clinical workflow strategies.
In March 2026, Butterfly Network announced the FDA cleared a blind sweep ultrasound AI system that automates capturing and estimating images without needing a read-trained sonographer. This advancement will reduce the reliance on operator skill, accelerate analysis promote more use at the point of care and thereby accelerate growth and operational efficiencies with AI-enabled workflows.
Market snapshot - (2026-2033)
Global Market Size
USD 2.22 Billion
Largest Segment
Handheld Ultrasound
Fastest Growth
Automated Breast Ultrasound (ABUS)
Growth Rate
7.42% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global breast ultrasound market is segmented by product type, technology, application, end-user and region. Based on product type, the market is segmented into Automated Breast Ultrasound (ABUS), Handheld Ultrasound and Portable Ultrasound. Based on technology, the market is segmented into 2D Ultrasound, 3D Ultrasound, 4D Ultrasound and Doppler Ultrasound. Based on application, the market is segmented into Breast Cancer Screening, Diagnostic Imaging and Biopsy Guidance. Based on end-user, the market is segmented into Hospitals, Radiology Centers and Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Automated breast ultrasound (ABUS) segment leads with global breast ultrasound market share as it standardizes the imaging process through its automated whole breast acquisition and thus improves lesion detection and reproducibility in dense tissue populations. The automated workflow allows for reduced variability in exams, provides for efficient centralized reading and image integration with advanced image analysis tools and is consistent with the clinical protocols that advocate for complete breast coverage. These operational efficiencies and consistent diagnosis create preference within institutions when considering procurement of breast imaging services.
According to the global breast ultrasound market outlook, handheld ultrasound segment is growing fastest because point-of-care imaging is creating demand, coupled with advancements in probe technology making it feasible for clinics and mobile screening. Knowledge among clinicians is leading to decreased capital requirements and software enhancements which result in increased adoption of handheld ultrasound technology provide additional diagnostic and guidance opportunities for practitioners performing breast care procedures and ultimately expand access to breast imaging.
As per global breast ultrasound market analysis, the 3D ultrasound segment is emergent because volumetric imaging captures spatial lesion characteristics that enhance morphological assessment and precise preprocedural planning in complex cases. Refined reconstructions and multiplanar views assist radiologists in differentiating benign from suspicious findings and ensure follow-up continuity. Coupled with advanced visualization software to be compatible with guidance workflows, this builds clinical confidence and adoption among diagnostic imaging centers focused on diagnosis accuracy and procedural efficiency.
As per global breast ultrasound market forecast, doppler ultrasound is set to be the fastest-growing technology in the market since vascular mapping adds the functional component important in lesion characterization and, as such, guides the planning of biopsy procedures. The sensitivity improvements, plus integration with elastography and contrast techniques and clinician demand for perfusion assessment in ambiguous cases is dovetailing with expanding Doppler use to expand diagnostic and interventional opportunities.
To get detailed segments analysis, Request a Free Sample Report
As per global breast ultrasound market regional outlook, North America dominates due to a combination of advanced healthcare infrastructure, early adoption of high-resolution imaging technologies, and a concentrated ecosystem of innovative device manufacturers and clinical research centers. Key contributors include: an advanced healthcare system, high initial implementation of the high-resolution imaging technologies, and a concentrate of innovative device manufacturers and clinical research facilities. Established screening pathways and diagnostic pathway workflows support demand for clinical procedures. Favorable reimbursement models and institutional purchasing procedures encourage adoption of this technology.
As per global breast ultrasound market regional forecast, United States is being shaped by innovations in the imaging field with significant emphasis on clinical implementations. The market is characterized by the type of devices used as well as by the adoption and implementation rate of the devices. The academic hospitals and private hospitals provide support for clinical practice validation and implementation of new technologies related to breast imaging. Additionally, the current reimbursement models and purchasing history have provided avenues for implementation across all hospital systems and supporting outpatient clinics.
In Canada, the breast ultrasound market is driven by the publicly funded healthcare system, its focus is on access and diagnostic networks in an equitable manner. Breast imaging programs and academic hospitals in Canada adhere to standard protocols and develop the training for clinicians on how to use breast ultrasound technologies. Investments have been made in first-generation portable ultrasound technologies that support a wide variety of community and remote locations. Centralized authorities and budgets are found in the procurement process, which impacts the efficiency and effectiveness of the purchasing and implementation processes in Canada. Collaboration between research institutes and device manufacturers enable the development and implementation of technologies specifically for Canadian care pathways.
As per global breast ultrasound industry analysis, Europe is currently undergoing rapid development due to the increasing recognition of ultrasound as an additional form of imaging to complement mammography, changes to clinical practice guidelines, and the investment into imaging infrastructure by national healthcare systems. The breast ultrasound industry is also experiencing increased adoption of new technology, particularly through the use of elastography and artificial intelligence (AI) in ultrasound interpretation, thanks to an established manufacturing base, collaboration networks among hospitals, universities, and technology companies, and the growing availability of private outpatient imaging centers that will provide additional access to imaging and diagnostic services to urban areas. The positive impact on increasing access to diagnostic services will also be enhanced by the increase in cross-border clinical trials and harmonization of regulatory structures, which will streamline the commercialization process for new and innovative diagnostic technologies.
The breast ultrasound market within Germany can be characterized by a highly developed and well-established medical device manufacturing industry, as well as a very dense network of university hospitals and breast centers that provide both clinical and academic resources to support the breast ultrasound industry. The high level of clinical research activity as well as the high level of education and training related to breast ultrasound, have supported and promoted the use of advanced breast imaging technologies in the German clinical arenas. The reimbursement and procurement structure for hospitals has provided a framework that encourages investment in high-quality ultrasound technology. The ongoing development of collaboration between manufacturers and clinical experts provides opportunities to develop tailored solutions that meet the specific needs of clinical care providers and outpatient imaging, further solidifying Germany's position as a leader in the breast imaging arena.
The breast ultrasound market in the U.K. is growing quickly due to the increase of outpatient imaging and private diagnostic imaging. The focus on improving access to diagnostic imaging through policies and community imaging has led to the increased use of both portable and advanced ultrasound platforms. In addition to this breast ultrasound market trend, there are now more specialist breast clinics and diagnostic chains leading to increased capacity and experience in the use of breast ultrasound and an increase in the availability of ultrasound at these facilities. The collaboration between clinical networks, technology start-ups and providers is also helping to expedite the roll-out of workflow solutions and training for operators which will further strengthen the integration of ultrasound into breast diagnostic pathways.
The breast ultrasound market in France is beginning to develop with many hospitals modernising their imaging suites and increasing their outpatient imaging capabilities. The professional societies are pushing towards the implementation of standardised protocols for breast ultrasound and training for operators, while collaborative research programs provide clinical validation of the new advanced modalities. The procurement decisions of hospitals have been heavily taken into account being cautious when implementing new technologies, while being mindful of the interoperability of systems, the competencies of clinicians, and alignment with the national priority for breast screening and diagnostic strategies.
The breast ultrasound market across Asia Pacific continues to grow due to the development of healthcare infrastructure, increased access to advanced imaging equipment, and local manufacturer involvement. The enhancement of radiology training centres and imaging specialties supports the proficiency of healthcare professionals, resulting in increased adoption beyond large urban hospitals. Supporting this is the establishment of collaborative partnerships between local and international device manufacturers which provides increased speed in the transfer of technology and local adaptation of devices to meet the broad range of uses encountered in different healthcare environments.
Japan breast ultrasound market is characterized by state-of-the-art technology, cooperation between the medical community and academia and clinical research into advanced imaging techniques. Local manufacturers and research institutions have developed high-quality platforms with integrated workflows for imaging. The emphasis on accurate diagnostic imaging and training for operators enables facilities and breast imaging centres to adopt will a high level of success.
South Korea breast ultrasound market benefits from rapid adoption of technology, strong local manufacturers of ultrasound devices, and many centres of excellence in breast imaging. Early adopters of AI imaging capabilities are hospitals and private clinics, as a result, they have been able to implement the use of these systems into their normal diagnostic imaging procedures with the assistance of clinical research and operator training projects.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Rising Demand For Early Detection
Technological Advancements In Imaging
High Cost Of Advanced Systems
Limited Reimbursement Coverage In Regions
Request Free Customization of this report to help us to meet your business objectives.
The competitive dynamics that shape the global breast ultrasound market are technology differentiation among vendors, regulatory clearances for devices to be used in their respective markets, and consolidation among manufactures. Established manufacturers are undertaking tuck in acquisitions to add capabilities to their respective product offerings. Companies are partnering, in an effort to integrate their software products, such as Qlarity Imaging partnering with other companies in order to offer broader access to their AI reporting capabilities. Additionally, product level disruptor companies, such as iSono Health are seeking FDA clearance for its wearable automated 3D breast ultrasound products.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global breast ultrasound market growth is being propelled by rising incidence and awareness of breast cancer as one key driver, while high acquisition and maintenance costs of advanced systems act as a significant restraint. North America remains the dominating region thanks to advanced infrastructure and favorable reimbursement and automated breast ultrasound ABUS is the dominating segment due to standardized whole breast acquisition that improves detection in dense tissue. A second driver is rapid AI integration and portable device development that enhance diagnostic accuracy and broaden point of care access, creating opportunities for manufacturers, payers, and health systems to expand screening and diagnostic services worldwide.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 2.22 Billion |
| Market size value in 2033 | USD 4.22 Billion |
| Growth Rate | 7.42% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Breast Ultrasound Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Breast Ultrasound Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Breast Ultrasound Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Breast Ultrasound Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Breast Ultrasound Market size was valued at USD 2.22 Billion in 2024 and is poised to grow from USD 2.38 Billion in 2025 to USD 4.22 Billion by 2033, growing at a CAGR of 7.42% during the forecast period (2026-2033).
Competitive dynamics in the global breast ultrasound market are driven by technology differentiation, regulatory clearances, and consolidation. Established vendors pursue tuck in acquisitions to add biopsy and localization capabilities as Hologic did with SOMATEX. Partnerships and software integrations such as Qlarity Imaging’s collaborations broaden AI enabled reporting, while innovators like iSono Health push product level disruption with FDA cleared wearable automated 3D breast ultrasound systems. 'GE Healthcare', 'Philips Healthcare', 'Siemens Healthineers', 'Hologic Inc. (Invenia ABUS)', 'Samsung Medison', 'Canon Medical Systems', 'Fujifilm Healthcare', 'SonoCiné', 'Mindray Medical', 'KOELIS', 'Solta Medical', 'Echopulse', 'Supersonic Imagine (Hologic)', 'Planmeca Oy', 'Clarius Mobile Health'
Rising awareness of the importance of early breast cancer detection motivates healthcare providers and patients to prioritize accessible, noninvasive diagnostic options, which in turn drives investment in ultrasound deployments and screening programs. As clinicians advocate for routine imaging and refer patients for ultrasound evaluation, demand for intuitive, reliable systems grows, encouraging manufacturers to expand product portfolios and distribution. This sustained clinical emphasis on early diagnosis supports broader market adoption of breast ultrasound solutions across varied care settings. Investment in complementary training and support further reinforces uptake.
Ai Enabled Diagnostic Support: Clinicians are adopting artificial intelligence tools to enhance image interpretation, lesion characterization, and workflow prioritization in breast ultrasound. These tools help standardize reporting, reduce variability tied to operator skill, and suggest adjunctive imaging when appropriate. Vendors focus on integrating machine learning models with existing systems and improving explainability to earn clinical trust. Regulatory acceptance and clinical validation are driving wider clinician engagement, enabling faster decision cycles and encouraging multidisciplinary adoption across screening, diagnostic evaluation, and treatment planning contexts across settings.
Why does North America Dominate the Global Breast Ultrasound Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
